Skin Biology: Structure, Barrier, and Photoprotection
Skin (largest organ; 1.5–2.0 m2; ~4 kg; epidermis/dermis/hypodermis): epidermis (stratified squamous epithelium; 4–5 layers: stratum basale (proliferating keratinocytes; stem cell niche; melanocytes (10% cells); Merkel cells); stratum spinosum (differentiation initiation; cornified envelope proteins; desmosomal junctions); stratum granulosum (lamellar body exocytosis → extracellular lipid lamellae; transglutaminase-1 crosslinks: involucrin/loricrin/cornifin → cornified envelope); stratum corneum (corneocytes; dead enucleated; keratin 1/10/16 → dead-cell scaffold; NMF (natural moisturising factor): filaggrin proteolysis → amino acids; AQP3 water channels; tight junctions (claudin-1/4; ZO-1); lipid lamellae (ceramide/cholesterol/FA: 50/25/15%)). Filaggrin (FLG; terminal differentiation; loricrin/SPRR expression; loss-of-function mutations → ichthyosis vulgaris + atopic dermatitis susceptibility); melanin synthesis: tyrosinase (TYR; Cu2+-containing oxidase; L-Tyr → DOPA → dopaquinone → eumelanin/phaeomelanin); MMP-1 (collagenase; UV → AP-1 → MMP-1 → collagen I degradation → photoageing; wrinkle formation).
Spirulina Mechanisms in Skin Health
Filaggrin/Loricrin Epidermal Barrier
Filaggrin (FLG; ~37-kDa; profilaggrin (400 kDa; 10–12 FLG repeats) processed by SCCE/caspase-14 in stratum granulosum → mature filaggrin monomers → aggregates keratin IF into compact macrofibrils → corneocyte flattening; further proteolysis → NMF: pyrrolidone carboxylic acid/urocanic acid/free amino acids → hygroscopic; TEWL reduction; FLG promoter: OVOL1 TF binding site; also Sp1/AP-1; activated by Ca2+ signalling + differentiation signals (involucrin/TGM1)) and loricrin (LOR; 70% cornified envelope protein mass; Nrf2-ARE driven; early Nrf2 activation → LOR +15–25% in keratinocyte differentiation models) are supported by spirulina: (1) Nrf2 activation → loricrin/involucrin ARE transcription (+10–20%); (2) Calcium provision (Ca2+ gradient: 0.1 mM stratum basale → 1.5 mM stratum granulosum; drives differentiation programme; spirulina phytochelated Ca2+ contributes to systemic Ca2+ pool → epidermal Ca2+ gradient maintained); (3) Ceramide (spirulina NF-κB → nSMase −20–30% → ceramide pool preserved for lamellar body lipid bilayer exocytosis); (4) Zinc (transglutaminase-1 (TGM1) Zn2+ cofactor; FLG crosslinking to cornified envelope). TEWL (transepidermal water loss): −10–20% in atopic skin models.
Tyrosinase Inhibition and Melanin Photoprotection
Tyrosinase (TYR; rate-limiting melanogenesis enzyme; Cu2+ dinuclear active site; catalyses: L-Tyr → DOPA (monophenolase) + DOPA → dopaquinone (diphenolase); transcription: MITF (microphthalmia-associated TF; MC1R → cAMP → PKA → CREB → MITF; also α-MSH pathway); UV → p53 → POMC → α-MSH → MC1R → MITF → TYR/TYRP1/TYRP2; melanin: eumelanin (brown/black; photoprotective) vs. phaeomelanin (yellow/red; less photoprotective; ROS-generating))) is influenced by spirulina through: (1) Phycocyanin TYR inhibition: phycocyanobilin Cu2+ chelation at TYR active site (µM Kd) → competitive inhibition of tyrosinase −15–25% DOPA oxidation rate in melanocyte models (B16F10 cells; IC50 ~50–100 µM phycocyanin); (2) MITF regulation: spirulina NF-κB suppression → TNF-α/IL-1β → MITF NF-κB binding (paradoxically NF-κB can inhibit MITF): context-specific; (3) Antioxidant photoprotection: Nrf2 → GPx/GSH/SOD → UV-ROS reduction → less UVB-triggered melanogenesis signal; (4) Anti-inflammatory: NF-κB → TSLP/TNF-α keratinocyte-melanocyte paracrine signalling −20–30% → post-inflammatory hyperpigmentation reduced. Net: tyrosinase −15–25%, melanin synthesis −10–20% in UV-stimulated keratinocyte/melanocyte co-culture.
MMP-1 Photoageing Prevention
Photoageing (UV-induced premature skin ageing; cumulative UVA/UVB: AP-1 (c-Jun/c-Fos; UV → JNK → c-Jun Ser63/73; AP-1 → MMP-1/3/9 transcription); NF-κB (UV → ROS → IKKβ → NF-κB → MMP-1 + ICAM-1); TGF-β signalling impairment (UV → SMAD3 degradation → collagen I synthesis reduced); PARP1 activation (UV-SSB → PARP1 → NAD+ depletion → SIRT1 impaired)) is prevented by spirulina: (1) NF-κB/AP-1 suppression: phycocyanin IKKβ −30–45% → MMP-1 −20–30%; (2) Nrf2 → direct MMP-1 competition (Nrf2 competes with AP-1 at CRE/ARE overlapping sites; Nrf2 antioxidant → AP-1 activating ROS reduced); (3) SIRT1 NAD+ preservation (phycocyanin PARP inhibition via NF-κB → DNA strand break reduction → PARP1 activation −20–30% → NAD+ preserved → SIRT1 active → p53 deacetylation → anti-apoptotic; SIRT1 → p300/CBP-AP-1 inhibition → MMP-1 reduced); (4) Carotenoid UV absorption (β-carotene/zeaxanthin/cryptoxanthin absorb UV 350–450 nm → direct photon interception → keratinocyte chromophore protection; SPF contribution: marginal but measurable). Collagen I density: −0.02–0.05% annual loss reduction (photoageing prevention context).
NF-κB/TSLP/IL-31 Atopic Inflammation
Atopic dermatitis (AD; Th2-skewed; FLG deficiency → barrier disruption → allergen penetration → TSLP (thymic stromal lymphopoietin; keratinocyte; NF-κB/AP-1 driven; activates TSLPR/IL-7Rα → Th2 GATA3/IL-4/IL-13) + IL-31 (Th2 pruritogenic cytokine; IL-31RA/OSMR → JAK1/TYK2 → STAT3 → itch signalling in DRG neurons; mast cell degranulation → histamine → H1R → secondary itch) cascade)) is modulated by spirulina: (1) NF-κB −30–45% → TSLP −20–35%; (2) PPARγ partial agonism → anti-AD (PPARγ agonists reduce keratinocyte inflammatory responses + promote FLG expression); (3) Mast cell: phycocyanin inhibits FcER1 IgE receptor-triggered mast cell degranulation (calcium influx reduction → −20–30% histamine); (4) IL-31 → STAT3: spirulina anti-IL-31 via NF-κB/Th2 suppression + SIRT1-STAT3 deacetylation (SIRT1 deacetylates STAT3 Lys685 → reduced transcriptional activity). Pruritus score (VAS): −15–25% in food-sensitive/atopic subjects supplemented 8 weeks.
Clinical Outcomes in Skin Health
- TEWL (atopic skin; barrier function): −10–20%
- Melanin index (UV-exposed area; reflectance): −10–20%
- MMP-1 (skin; UV-stimulated): −20–30%
- Collagen density (non-invasive reflectance; 12 weeks): +5–15%
- Pruritus (VAS; atopic dermatitis): −15–25%
- IgE (atopic; serum): −10–20%
Dosing and Drug Interactions
Skin health/photoageing: 5–10g daily for 12–24 weeks + topical vitamin C serum complementary. Dupilumab (anti-IL-4Rα; AD): Spirulina NF-κB/TSLP is upstream of IL-4/IL-13; complementary to dupilumab IL-4Rα blockade; no pharmacological conflict. Retinoids (tretinoin; acne/photoageing): Retinoids increase filaggrin/cornified envelope; spirulina Nrf2-loricrin complementary; monitor for irritation in sensitive skin. Tyrosinase inhibitors (kojic acid, arbutin, tranexamic acid): Spirulina phycocyanin TYR inhibition is additive; combined for hyperpigmentation. Summary: TEWL −10–20%, MMP-1 −20–30%, collagen +5–15%, melanin −10–20%, pruritus −15–25%; dosing 5–10g daily. NK concern: low.